These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2788755)

  • 21. Specific binding of sterically stabilized anti-B-cell immunoliposomes and cytotoxicity of entrapped doxorubicin.
    Lundberg BB; Griffiths G; Hansen HJ
    Int J Pharm; 2000 Sep; 205(1-2):101-8. PubMed ID: 11000546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma.
    Lopes de Menezes DE; Pilarski LM; Allen TM
    Cancer Res; 1998 Aug; 58(15):3320-30. PubMed ID: 9699662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Preparation of monoclonal antibodies against ovarian carcinoma bearing chemical drugs entrapped in liposomes and the cytotoxic tests to carcinoma cells].
    Li WJ
    Zhonghua Fu Chan Ke Za Zhi; 1993 Oct; 28(10):604-7, 635-6. PubMed ID: 8112131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor effect of adriamycin entrapped in liposomes conjugated with anti-bovine tumor antigen monoclonal antibody in leukemic cows.
    Onuma M; Yasutomi Y; Yamamoto M; Watarai S; Yasuda T; Kawakami Y
    Zentralbl Veterinarmed B; 1989 Mar; 36(2):139-47. PubMed ID: 2546342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody.
    Lukyanov AN; Elbayoumi TA; Chakilam AR; Torchilin VP
    J Control Release; 2004 Nov; 100(1):135-44. PubMed ID: 15491817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibody 2C5-modified doxorubicin-loaded liposomes with significantly enhanced therapeutic activity against intracranial human brain U-87 MG tumor xenografts in nude mice.
    Gupta B; Torchilin VP
    Cancer Immunol Immunother; 2007 Aug; 56(8):1215-23. PubMed ID: 17219149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.
    Sugano M; Egilmez NK; Yokota SJ; Chen FA; Harding J; Huang SK; Bankert RB
    Cancer Res; 2000 Dec; 60(24):6942-9. PubMed ID: 11156394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The antitumor effect of adriamycin conjugated with monoclonal antibody against gastric cancer in vitro and in vivo].
    Zhang YT; Wang NQ; Li N; Liu T; Dong ZW
    Yao Xue Xue Bao; 1992; 27(5):325-30. PubMed ID: 1442051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting her-2/neu with antirat Neu virosomes for cancer therapy.
    Waelti E; Wegmann N; Schwaninger R; Wetterwald A; Wingenfeld C; Rothen-Rutishauser B; Gimmi CD
    Cancer Res; 2002 Jan; 62(2):437-44. PubMed ID: 11809693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of adriamycin delivery to liver metastatic cells with increased tumoricidal effect using liposomes as drug carriers.
    Gabizon A; Goren D; Fuks Z; Barenholz Y; Dagan A; Meshorer A
    Cancer Res; 1983 Oct; 43(10):4730-5. PubMed ID: 6883331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Selective hepatic arterial infusion of liposomes containing antitumor agents].
    Kumai K; Takahashi T; Tsubouchi T; Yoshino K; Ishibiki K; Abe O
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):1946-8. PubMed ID: 4051510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor effects of liposomes containing adriamycin on chemically-induced rat malignant fibrous histiocytoma.
    Nishida K; Yonemura K; Abe Y; Takagi K
    Nihon Seikeigeka Gakkai Zasshi; 1995 May; 69(5):322-31. PubMed ID: 7797953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of human tumor growth in nude mice by a conjugate of doxorubicin with monoclonal antibodies to epidermal growth factor receptor.
    Aboud-Pirak E; Hurwitz E; Bellot F; Schlessinger J; Sela M
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3778-81. PubMed ID: 2786202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Membrane alterations by liposomes to enhance clinical efficacy of cytotoxic drugs.
    Rahman A; Dusre L; Forst D; Thierry A; Roh JK; Greenspan A; Treat J
    Prog Clin Biol Res; 1990; 343():281-304. PubMed ID: 2377628
    [No Abstract]   [Full Text] [Related]  

  • 35. Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells.
    Mamot C; Drummond DC; Greiser U; Hong K; Kirpotin DB; Marks JD; Park JW
    Cancer Res; 2003 Jun; 63(12):3154-61. PubMed ID: 12810643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a monoclonal antibody, TV-1, directed against the basement membrane of tumor vessels, and its use to enhance the delivery of macromolecules to tumors after conjugation with interleukin 2.
    Epstein AL; Khawli LA; Hornick JL; Taylor CR
    Cancer Res; 1995 Jun; 55(12):2673-80. PubMed ID: 7780984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor activity of adriamycin (hydrazone-linked) immunoconjugates compared with free adriamycin and specificity of tumor cell killing.
    Braslawsky GR; Edson MA; Pearce W; Kaneko T; Greenfield RS
    Cancer Res; 1990 Oct; 50(20):6608-14. PubMed ID: 2208123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiproliferative effect of immunoliposomes containing 5-fluorodeoxyuridine-dipalmitate on colon cancer cells.
    Koning GA; Gorter A; Scherphof GL; Kamps JA
    Br J Cancer; 1999 Aug; 80(11):1718-25. PubMed ID: 10468287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mode of binding of adriamycin with sulfatide-containing liposomes.
    Takano M; Kojima N; Yagi K
    Biochem Int; 1988 Jul; 17(1):77-86. PubMed ID: 3190718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of adriamycin against a liver metastatic model by encapsulation in liposomes.
    Yachi K; Suzuki N; Tanaka N; Okada K; Mitsui I; Kawato Y; Komagata Y; Komiyama K; Kikuchi H
    Biopharm Drug Dispos; 1996 Nov; 17(8):699-715. PubMed ID: 8950048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.